Eurofins Scientific SE

Chart & Performance

D1W1MN

P/E

28.16

P/S

1.34

EPS

1.62

Div Yield, %

2.13%

Shrs. gr., 5y

1.58%

Rev. gr., 5y

11.49%

Revenues

6.51b

-2.94%

Net income

310m

-49.15%

CFO

1.02b

-10.42%

Dividend

Jul 03, 20240.537 USD/sh

Earnings

Feb 25, 2025

Profile

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of approximately 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agro-science, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, and healthcare and cosmetics; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include product compliance and audit, testing, certifications and approvals, inspections, training courses, and digital media and cyber security for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, authenticity, carbohydrates, consulting, dioxins and POPs, food irradiation, labelling, law, heavy metals, identity preservation, mealtime, molecular and microbiology, mycotoxins, nutritional analyses, organic containments, packaging/migration, radioactivity, rapidest, sensorsy and consumer research, trainings, veterinary drug residues, and vitamins services. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and technologies services. It operates approximately 900 laboratories in 54 countries. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.

URL

https://www.eurofins.com/

IPO date

Oct 24, 1997

Employees

62,000

Domiciled in

Incorporated in

Valuation

Order:

Title EUR in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title EUR in thousands, except ratios and share amounts	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12	2015‑12
Income
Revenues	6,514,600 -2.94%	6,712,100 -0.08%
Cost of revenue	5,894,200	2,227,000
Unusual Expense (Income)
NOPBT	620,400	4,485,100
NOPBT Margin	9.52%	66.82%
Operating Taxes	115,500	174,200
Tax Rate	18.62%	3.88%
NOPAT	504,900	4,310,900
Net income	310,300 -49.15%	610,200 -22.03%
Dividends	(191,900)	(192,100)
Dividend yield	1.64%	1.44%
Proceeds from repurchase of equity	(47,800)	(1,200)
BB yield	0.41%	0.01%
Debt
Debt current	601,000	213,700
Long-term debt	3,904,300	3,639,400
Deferred revenue	1,000,000
Other long-term liabilities	1,194,000	214,900
Net debt	3,200,500	3,282,900
Cash flow
Cash from operating activities	1,017,900	1,136,300
CAPEX	(478,100)	(660,200)
Cash from investing activities	(681,100)	(855,900)
Cash from financing activities	495,800	(311,300)
FCF	292,200	3,906,800
Balance
Cash	1,221,200	486,600
Long term investments	83,600	83,600
Excess cash	979,070	234,595
Stockholders' equity	4,192,300	4,282,500
Invested Capital	8,278,830	7,616,705
ROIC	6.35%	60.13%
ROCE	6.62%	56.17%
EV
Common stock shares outstanding	197,900	199,000
Price	58.98 -12.05%	67.06 -38.36%
Market cap	11,672,142 -12.54%	13,344,940 -38.86%
EV	14,932,542	16,696,740
EBITDA	1,185,400	4,989,500
EV/EBITDA	12.60	3.35
Interest	129,400	105,600
Interest/NOPBT	20.86%	2.35%